NCT00695916

MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery

Withdrawn Phase 3 Last updated 1 February 2017

What this trial tests

Phase 3 trial testing Breast MRI in Breast Cancer. Withdrawn.

Quick facts

Lead sponsor	Stanford University
Phase	Phase 3
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic

Drugs / interventions tested

• Breast MRI

Conditions studied

• Breast Cancer — all drugs for Breast Cancer →

Sponsor

Stanford University

Who can join

18 and older, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To see if performing breast MRI before a lumpectomy will help the surgeon successfully remove the entire cancer with normal tissue margins in a single operation thereby reducing the need for additional surgical procedures. The study will also measure how well MRI can find unsuspected cancers in the same breast as the known cancer; how well MRI will find unsuspected cancers in the opposite breast; how often MRI will generate false positive MRI findings; whether routinely incorporating breast MRI delays care or adds unnecessary cost; and, whether breast MRI is able to reduce the frequency of cancer recurrence in the treated breast or elsewhere in the body.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.